MANETTI, MIRKO
 Distribuzione geografica
Continente #
NA - Nord America 16.672
EU - Europa 10.810
AS - Asia 8.529
SA - Sud America 1.402
AF - Africa 304
OC - Oceania 174
Continente sconosciuto - Info sul continente non disponibili 8
Totale 37.899
Nazione #
US - Stati Uniti d'America 16.427
RU - Federazione Russa 3.557
SG - Singapore 2.365
IT - Italia 2.199
CN - Cina 2.100
PL - Polonia 1.688
HK - Hong Kong 1.160
BR - Brasile 1.112
VN - Vietnam 918
IE - Irlanda 862
KR - Corea 762
SE - Svezia 721
FR - Francia 434
FI - Finlandia 383
DE - Germania 320
IN - India 312
BD - Bangladesh 213
GB - Regno Unito 208
AU - Australia 172
JP - Giappone 147
CA - Canada 145
ID - Indonesia 121
JO - Giordania 104
AR - Argentina 101
NL - Olanda 95
UA - Ucraina 80
IQ - Iraq 66
CI - Costa d'Avorio 63
ES - Italia 63
TR - Turchia 59
MX - Messico 58
ZA - Sudafrica 50
EC - Ecuador 47
MA - Marocco 46
CH - Svizzera 40
CO - Colombia 35
PH - Filippine 35
PK - Pakistan 34
NG - Nigeria 33
VE - Venezuela 27
BE - Belgio 25
PY - Paraguay 23
TN - Tunisia 20
CL - Cile 19
AZ - Azerbaigian 18
LT - Lituania 18
EG - Egitto 17
SA - Arabia Saudita 17
UZ - Uzbekistan 17
PE - Perù 16
AT - Austria 15
UY - Uruguay 15
BJ - Benin 13
AE - Emirati Arabi Uniti 12
KE - Kenya 12
RO - Romania 12
UG - Uganda 11
JM - Giamaica 10
NP - Nepal 10
DK - Danimarca 9
LV - Lettonia 9
MK - Macedonia 9
CZ - Repubblica Ceca 8
KZ - Kazakistan 8
LU - Lussemburgo 8
SC - Seychelles 8
TH - Thailandia 8
NO - Norvegia 7
SN - Senegal 7
GR - Grecia 6
BO - Bolivia 5
DZ - Algeria 5
HN - Honduras 5
MD - Moldavia 5
AL - Albania 4
BG - Bulgaria 4
CG - Congo 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
EU - Europa 4
IR - Iran 4
KG - Kirghizistan 4
LB - Libano 4
ML - Mali 4
PS - Palestinian Territory 4
RS - Serbia 4
TW - Taiwan 4
BB - Barbados 3
BY - Bielorussia 3
GT - Guatemala 3
IL - Israele 3
LK - Sri Lanka 3
PA - Panama 3
PT - Portogallo 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
Totale 37.860
Città #
Santa Clara 3.131
Ashburn 2.187
Singapore 1.797
Warsaw 1.680
Fairfield 1.508
Hong Kong 965
Dublin 844
Seoul 754
Chandler 732
Woodbridge 685
Seattle 612
Cambridge 605
Houston 576
San Jose 538
Hefei 505
Wilmington 464
Milan 438
Beijing 393
Ho Chi Minh City 292
Los Angeles 268
Florence 265
Ann Arbor 226
Lauterbourg 225
Princeton 222
Hanoi 220
Lawrence 213
Altamura 206
The Dalles 197
Buffalo 184
Rome 171
Helsinki 165
Dallas 161
Moscow 157
Mumbai 154
New York 149
Melbourne 146
Council Bluffs 144
Medford 138
Munich 136
Tokyo 133
Paris 125
Boston 121
Jacksonville 121
Boardman 120
São Paulo 107
San Diego 90
Jakarta 83
Shanghai 79
Kent 73
Abidjan 63
Clifton 61
Redondo Beach 58
Orem 54
Chicago 53
Falls Church 51
Montreal 49
London 48
Turku 47
Naples 45
Chennai 44
Guangzhou 41
Turin 41
Dong Ket 40
Norwalk 40
Rio de Janeiro 39
Figino 37
Lappeenranta 37
Toronto 37
Atlanta 36
Da Nang 36
Frankfurt am Main 36
Phoenix 35
Abuja 33
Johannesburg 33
Zeist 32
Brooklyn 30
Baghdad 29
Hillsboro 29
Bologna 28
Haiphong 28
Barcelona 24
Bengaluru 23
Palermo 23
Tianjin 23
Yubileyny 23
Andover 22
Casablanca 22
Miano 22
Shenzhen 22
Belo Horizonte 21
Genoa 21
Izmir 21
Pune 21
Biên Hòa 20
Denver 20
Padua 20
Bern 19
Fiesole 19
Manchester 19
Porto Alegre 19
Totale 25.199
Nome #
Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide 358
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis 341
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis 336
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 332
Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic Implications 305
The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem? 296
Multimodal imaging in the diagnosis and evaluation of intestinal malrotations in adults: a case report 290
Anti-Fas IgM monoclonal antibody (anti-Fas mAb) effect on haemophilic arthropathy (HA) synoviocytes 288
Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide 277
Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A 266
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 265
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 262
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis 257
Longitudinal assessment of the impact of adapted physical activity on upper limb disability and quality of life in breast cancer survivors from an Italian cohort 249
A case of in vivo iontophoresis-assisted corneal collagen cross-linking for keratoconus: An immunohistochemical study 246
Psychological well-being and quality of life in visually impaired baseball players: An Italian national survey 246
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 241
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications 227
A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis 227
Role of a Structured Physical Activity Pathway in Improving Functional Disability, Pain and Quality of Life in a Case of Breast and Gynecological Cancer Survivorship 225
A case of mandible hypoplasia treated with autologous bone graft from mandibular symphysis: Expression of VEGF and receptors in bone regeneration. 218
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 215
Telocytes in normal and keratoconic human cornea: an immunohistochemical and transmission electron microscopy study 215
A two-step immunomagnetic microbead-based method for the isolation of human primary skin telocytes/CD34+ stromal cells 214
Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? 213
Systemic sclerosis-like histopathological features in the myocardium of uPAR-deficient mice 210
TNF-α/TNF-R System May Represent a Crucial Mediator of Proliferative Synovitis in Hemophilia A 209
Self-reported active lifestyle behavior and upper limb disability in breast cancer survivors following a structured adapted physical activity intervention 207
Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium 206
Pathophysiology of Hemophilic Arthropathy 205
Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications 204
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 204
Adapted Training to Boost Upper Body Sensorimotor Control and Daily Living Functionality in Visually Impaired Baseball Players 202
Severe fibrotic changes and altered expression of angiogenic factors in maternal scleroderma: placental findings. 201
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro 200
Long-Term Benefits of Adapted Physical Activity on Upper Limb Performance and Quality of Life in Breast Cancer Survivors 197
Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report 196
Cardiac Telocyte-Derived Exosomes and Their Possible Implications in Cardiovascular Pathophysiology 196
Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome 195
Bone Marrow-Mesenchymal Stromal Cell Secretome as Conditioned Medium Relieves Experimental Skeletal Muscle Damage Induced by Ex Vivo Eccentric Contraction 192
Visually impaired dancers vs other sound input-based sport athletes: survey on psychological well-being and quality of life 191
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 191
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 190
Targeting anticoagulant protein S to improve hemostasis in hemophilia 190
Co-expression of the SARS-CoV-2 entry receptors ACE2 and TMPRSS2 in healthy human conjunctiva 189
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 188
Reappraising the microscopic anatomy of human testis: identification of telocyte networks in the peritubular and intertubular stromal space 188
Effectiveness of an Adapted Physical Activity Protocol for Upper Extremity Recovery and Quality of Life Improvement in a Case of Seroma after Breast Cancer Treatment 186
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 183
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 182
Blocking Protein S Improves Hemostasis in Hemophilia A and B 182
XIII National Congress SISMES - Feasibility and efficacy of an adapted physical activity protocol during COVID-19 pandemic: lower limb functional and strength recovery in a young athlete affected by cutaneous melanoma 181
DECIPHERING THE GUT MICROBIOTA OF VERY EARLY SYSTEMIC SCLEROSIS (VEDOSS) PATIENTS: A TAXONOMIC AND FUNCTIONAL CHARACTERIZATION 181
Adapted Physical Activity Protocol for Lower Limb Functional and Strength Recovery in a Young Athlete with Cutaneous Melanoma: Feasibility and Efficacy during COVID-19 Pandemic 181
Morphological evidence for telocytes as stromal cells supporting satellite cell activation in eccentric contraction-induced skeletal muscle injury 181
Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis 181
Stiff skin syndrome: evidence for an inflammation-independent fibrosis? 180
Changes in the telocyte/CD34+ stromal cell and α-SMA+ myoid cell networks in human testicular seminoma 180
Effects of a specific adapted upper limb exercise on lymphedema in breast cancer survivors: a pilot study 179
Adapted physical activity protocol for the management of breast cancer-related upper limb lymphedema 178
Evidence for the prevention of enthesitis in HLA-B27/hβ(2)m transgenic rats treated with a monoclonal antibody against TNF-α. 178
Blockade of Sialylation with Decrease in Polysialic Acid Levels Counteracts Transforming Growth Factor β1-Induced Skin Fibroblast-to-Myofibroblast Transition 177
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 177
Characterization and distribution of sialic acids in human testicular seminoma 177
Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis 177
Quality of life improvement in breast cancer survivors affected by upper limb lymphedema through a novel multiperspective physical activity methodology: a monocentric pilot study 177
Do new and old biomarkers of early undifferentiated arthritis correlate with Arthritis Impact Measurement Scales? 176
Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosis 175
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis 175
Extracellular lactic acidosis drives reprogramming of human subcutaneous adipocytes toward pathogenic myofibroblasts 174
Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence 174
Neuropeptides activate TRPV1 in rheumatoid arthritis fibroblast-like synoviocytes and foster IL-6 and IL-8 production. 173
Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Inhibitors Correlates with Increased Soluble Fas Levels. 173
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis 173
Telocytes are reduced during fibrotic remodelling of the colonic wall in ulcerative colitis 173
Tailored sailing experience to reduce psychological distress and improve the quality of life of breast cancer survivors: A survey-based pilot study 173
Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts 172
A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis 172
Occult spondyloarthritis in inflammatory bowel disease 171
Concomitant Spondyloarthritis and Tenosynovial Giant Cell Tumor in Pigmented Villonodular Synovitis Challenging Cases 170
Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis 169
Post-COVID-19 Small Fiber Neuropathy as a New Emerging Quality of Life-Threatening Disease: A Systematic Review 168
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 168
Female blind baseball players against gender discrimination: the "red diamonds" experience 167
Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma? 167
Skin telocyte secretome as conditioned medium prevents profibrotic differentiation of skin fibroblasts into myofibroblasts 166
A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis 166
Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage 166
Survey on Psychological Well-Being and Quality of Life in Visually Impaired Individuals: Dancesport vs. Other Sound Input-Based Sports 166
Morphological evidence of telocytes in human synovium 165
Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis 164
Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis 164
Differential expression of junctional adhesion molecules in different stages of systemic sclerosis 164
Insulin-like growth factor binding protein 6 in rheumatoid arthritis: A possible novel chemotactic factor? 164
Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis 162
Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis 162
Physical activity and sport practice to improve balance control of visually impaired individuals: a narrative review with future perspectives 161
Lymphatic endothelial progenitor cells and vascular endothelial growth factor-C in spondyloarthritis and Crohn’s disease: two overlapping diseases? 161
Scleroderma-like Impairment in the Network of Telocytes/CD34+ Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis 161
Reactive agility and pitching performance improvement in visually impaired competitive Italian baseball players: an innovative training and evaluation proposal 160
Totale 20.093
Categoria #
all - tutte 106.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.521


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.363 30 84 72 71 57 112 51 64 101 83 144 494
2022/20233.474 374 641 149 245 231 637 489 187 325 48 84 64
2023/20241.460 43 174 281 72 104 198 84 233 22 78 98 73
2024/202510.189 380 1.072 701 1.486 2.962 1.051 334 587 462 321 369 464
2025/202613.860 1.301 1.676 1.374 1.467 1.418 509 1.536 719 978 788 539 1.555
2026/2027153 153 0 0 0 0 0 0 0 0 0 0 0
Totale 38.508